(Q83306197)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Does age matter in the selection of treatment for men with early-stage prostate cancer? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Andre Konski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Debra Eisenberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Eric Horwitz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Alexandra Hanlon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Alan Pollack

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Gerald Hanks

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

2598-2602

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

IS CARCINOMA OF THE PROSTATE LESS SERIOUS IN OLDER MEN?

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21923

Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21923

7 January 2021

Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21923

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21923

7 January 2021

A comparison by age of death rates due to prostate cancer alone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21923

7 January 2021

Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system: a radiation oncology report of the Department of Defense Center for Prostate Disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21923

7 January 2021

Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21923

7 January 2021

Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21923

7 January 2021

Effect of young age on prostate cancer survival: a population-based assessment (United States).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21923

7 January 2021

Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21923

7 January 2021

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21923

7 January 2021

Time and PSA threshold model prognosticates long-term overall and disease-specific survival in prostate cancer patients as early as 3 months after external beam radiation therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21923

7 January 2021

Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21923

7 January 2021

Identifiers

DOI

10.1002/CNCR.21923

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16683224%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference